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Learning 
objectives 
After completing this module students and public health 
professionals should:  
• understand the idea of settings approach to health promotion; 
• be aware of four areas of Health Promoting Hospitals (HPH) 
strategy; 
• recognize the benefits of health promotion (HP) in hospitals; 
• understand the purpose, structure and functioning of 
International Network of HPH; 
• be familiar with standards and core strategies for HPH; 
• acknowledge the importance of new HP and disease 
prevention services in HPH; 
• recognize the importance of patients' empowerment for health 
promoting management of chronic disease. 
Abstract The Ottawa Charter for Health Promotion put forward the idea 
that health is created and lived by people within the settings of 
their everyday life. This settings approach to HP led to a number 
of initiatives, among them HPH.  
The HPH strategy focuses on four areas: promoting the 
health of patients, promoting the health of staff, changing the 
organization to a health promoting setting, and promoting the 
health of the community in the catchments area of the hospital. 
The need for and the relevance of setting standards for HP in 
hospitals was realized in the International Network of HPH, which 
acts as a network of networks linking all national and/or regional 
networks. It supports the exchange of ideas and strategies 
implemented in different cultures and health care systems, 
developing knowledge on strategic issues and enlarging the vision. 
Nowadays, the International Network of HPH comprises 30 
member states, 33 national and/or regional networks and more 
than 650 hospitals. 
There is international consensus that patients should be 
given recommendations, guidance, and support with regard to HP 
in hospitals. An important element is the activation of the patient’s 
individual resources and competences in coping with disease. 
Example of effective intervention of this type of services is the 
case of Golnik hospital, where introducing specific type of 
treatment for specific group of patients has developed from 
hospital vision to national clinical pathway implementation. 
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Teaching 
methods 
Teaching methods include introductory lectures, exercises, and 
interactive methods such as small group discussions. 
After introductory lectures students should choose one of 
the HPH and try to find out if activities are carried out on all 
four areas of HPH strategy. 
Afterwards they should carefully read the case study and 
try to develop their own program for empowerment of patients 
for health promoting management of specific chronic disease.  
Specific 
recommendation
s for teachers 
• work under teacher supervision/individual students’ work 
proportion: 30%/70%; 
• facilities: a computer room; 
• equipment: computers (1 computer on 2-3 students), LCD 
projection equipment, internet connection, access to the 
bibliographic data-bases; 
• training materials: recommended readings or other related 
readings; 
• target audience: master degree students according to 
Bologna scheme. 
Assessment of 
students 
Assessment is based on seminar paper and oral exam. 
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HOSPITAL IN MEETING COMPREHENSIVE HEALTH 
GOALS 
Mitja Košnik, Jerneja Farkaš-Lainščak 
 
 
 
THEORETICAL BACKGROUND 
Basics of health promotion 
Health promotion is defined as the process of enabling people to increase control over, and 
improve their health (1). Health promotion goes beyond health education and disease 
prevention in as far as it is based on the concept of salutogenesis and stresses the analysis 
and development of the health potential of individuals (2). Health in this context not only 
refers to the traditional, objective and biomedical view of the absence of infirmity or 
disease but to a holistic view that adds mental resources and social well-being to physical 
health (3, 4). The statement of principles known as the Ottawa Charter for Health 
Promotion (1), developed by the World Health Organization (WHO) in 1986, is 
internationally accepted as the guiding framework for health promotion activity.  
 
 
Settings approach to health promotion 
Based on the notion of health as a positive concept, the Ottawa Charter for Health 
Promotion put forward the idea that health is created and lived by people within the 
settings of their everyday life. This settings approach to health promotion, founded on 
the experience of community and organizational development, led to a number of 
initiatives such as Healthy Cities, Health Promoting Schools, Health Promoting 
Workplaces, Health Promoting Hospitals (HPH), etc. in order to improve people’s 
health where they spend most of their time (5). The settings approach acknowledges 
that behavioural changes are only possible and stable if they are integrated into 
everyday life and correspond with concurrent habits and existing cultures (6). 
 
 
Development of the Health Promoting Hospitals concept  
Twenty years ago, WHO initiated HPH movement in order to support hospitals towards 
placing greater emphasis on health promotion and disease prevention, rather than on 
diagnostic and curative services alone. The HPH strategy focuses on four areas: 
promoting the health of patients, promoting the health of staff, changing the 
organization to a health promoting setting, and promoting the health of the community 
in the catchments area of the hospital (7). These four areas are reflected in the 
definition of a HPH, which states that HPH does not only provide high quality 
comprehensive medical and nursing services, but also develops a corporate identity that 
embraces the aims of health promotion, develops a health promoting organizational 
structure and culture, including active, participatory roles for patients and all members 
of staff, develops itself into a health promoting physical environment, and actively 
cooperates with its community (4).  
 
Promoting the health of patients 
Health professionals in hospitals can have a lasting impact on influencing the behaviour of 
patients and relatives, who are more responsive to health advice in situations of  
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experienced disease (8). This is of particular importance for two reasons: firstly, the 
prevalence of chronic diseases is increasing in Europe and throughout the world (9); 
secondly, many hospital  
treatments today not only prevent premature death but improve the quality of life of 
patients (10). In order to maintain this quality, the patient’s own behaviour after discharge 
and effective support from relatives are important variables. Therefore, one of the HPH's 
priorities is to encourage healthy behaviour, prevent readmissions and maintain quality of 
life of patients (7).  
 
Promoting the health of staff 
Paradoxically, in hospitals – organizations that aim to restore health – the 
acknowledgement of factors that endanger the health of their staff is poorly developed 
(11). These working places, most of which are occupied by women, are characterized by 
certain physical, chemical, biological and psychosocial risk factors. With the increasing 
lack and migration of health professionals, hospitals have to compete for the best staff. 
Hospitals that offer a safe and health promoting working environment and that involve 
staff in creating such an environment will be more successful to attract, recruit and retain 
staff (12). Health promotion programmes can improve the health of staff, reduce costly 
short-term absenteeism rates, and improve productivity and quality (13). 
 
Changing the organization to a health promoting setting and 
promoting the health of the local community 
Hospitals also typically produce high amounts of waste and hazardous substances. 
Introducing health promotion strategies in hospitals can help reduce the pollution of the 
environment and the cooperation with other institutions and professionals can help achieve 
the highest possible coordination of care. Furthermore, as research and teaching 
institutions hospital produce, accumulate and disseminate a lot of knowledge and they can 
have an impact on the local health structures and influence professional practice elsewhere 
(7). In this context, hospitals are expected to expand their role beyond the curative services 
to a pro-acting vehicle for health improvement. Towards this aim, HPH target the health of 
individuals (staff, patients, local community population) but they promote the health of 
their organization as well, by creating a sustainable organization, capable of confronting 
today’s challenges (14). 
 
 
Evolution of the International Network of Health Promoting 
Hospitals 
A first connection between hospitals and health promotion appeared at the end of the 1970s 
when health promotion and disease prevention came up in the United States as additional 
professional services provided by the hospital (15). In order to support the introduction of 
health promotion programmes in hospitals, the WHO Regional Office for Europe started 
the first international consultations in 1988. In the subsequent year, the WHO model 
project »Health and Hospital« was initiated with the Rudolfstiftung Hospital in Vienna, as 
a partner institution (13). After this phase of consultation and experimenting the HPH 
movement went into its developmental phase, being marked by the initiation of the 
European Pilot Hospital Project by the WHO Regional Office for Europe in 1993. This 
phase, which lasted from 1993 to 1997, involved intensive monitoring of the development 
of projects in 20 partner hospitals from 11 European countries (Austria, Czech Republic,  
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France, Germany, United Kingdom, Greece, Hungary, Ireland, Italy, Poland, and Sweden) 
(16). 
Subsequent to the closing of this pilot phase, national and regional networks were 
developed and the network reached its consolidation phase. Since then, national and 
regional networks take an important role in encouraging the cooperation and exchange of 
experience between hospitals of a region or a country, including the identification of areas 
of common interest, the sharing of resources and the development of common evaluation 
systems. The International Network of HPH acts as a network of networks linking all 
national and/or regional networks. It supports the exchange of ideas and strategies 
implemented in different cultures and health care systems, developing knowledge on 
strategic issues and enlarging the vision. Nowadays, the International Network of HPH 
comprises 30 member states, 33 national and/or regional networks and more than 650 
hospitals (17). 
Many more countries and hospitals are regularly participating in the annual 
international HPH conferences which have been organized since 1993 in Warsaw, Padova, 
Linköping, Londonderry, Vienna, Darmstadt, Swansea, Athens, Copenhagen, Bratislava, 
Florence, Moscow, Dublin, Lithuania, Vienna and - in 2008 - Berlin. A semi-annual HPH 
Newsletter has been issued also since 1993.  
In addition to the national and/or regional networks, specific HPH task forces put 
efforts into further developing the HPH concept for specific thematic areas or for specific 
hospital types (e.g. Health promoting psychiatric health care services, Health promotion for 
children and adolescents in the hospital, Migrant friendly and culturally competent 
hospitals, Putting HPH policy into action (18 HPH core strategies), Standards for HPH and 
quality-based reimbursement) (16).  
The HPH network is currently developing into an international association. It is 
governed by an elected international governance board and has a general assembly meeting 
once a year. The secretariat is based at the WHO Collaborating Centre for Evidence Based 
Health Promotion in Hospitals in Copenhagen (18). The international HPH conferences, 
the international HPH Newsletter and other scientific and technical functions are supported 
by the WHO Collaborating Centre for Health Promotion in Hospitals and Health Care, 
which is situated in Vienna (19). 
Subsequently, the progress of HPH has resulted in a series of influential reports that 
include The Budapest Declaration on Health Promoting Hospitals, The Ljubljana Charter 
on Reforming Health Care, and The Vienna Recommendations on Health Promoting 
Hospitals (20-22). The latest document forms the set of principles on which the HPH 
concept is based. According to them a HPH should: 
1. promote human dignity, equity, solidarity, and professional ethics, acknowledging 
differences in needs, values and culture of different population groups; 
2. be oriented towards quality improvement, the well-being of patients, relatives and 
staff, protection of the environment and realization of the potential to become a 
learning organization; 
3. focus on health with a holistic approach and not only on curative services; 
4. be centred on people providing health services in the best way possible for patients 
and relatives to facilitate the healing process and contribute to the empowerment of 
patients; 
5. use resources efficiently, cost-effectively and allocate resources on the basis of 
contribution to health improvement; 
6. form as close link as possible with other levels of the health care system and the 
community (22). 
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Standards and core strategies for Health Promoting Hospitals  
The need for and the relevance of setting standards for health promotion in hospitals was 
realized in the International Network of HPH. Over a 2-year period a set of standards was 
developed in order to make the standards applicable and acceptable in all hospitals and in 
order to make it possible to integrate the standards in existing quality standards for 
hospitals as established by several international and national quality and accreditation 
organizations (7). The standards have now been through a pilot test, which has confirmed 
that they are understandable, meaningful, relevant and applicable. International quality 
organizations are encouraged to integrate the standards in their already established sets of 
standards and in the future use of the standards. The final set of five standards concern: 
Management Policy, Patient Assessment, Patient Information and Intervention, Promoting 
a Healthy Workplace, and Continuity and Cooperation (23). The standards relate to patient 
pathways and define responsibilities and activities concerning health promotion as an 
integrated part of all services offered to patients in every hospital. Each standard consists 
of a standard formulation, objective and definition of sub standards (24). 
In 2001, WHO launched a working group to develop an up-to-date strategic 
framework for HPH since the situation of hospitals is characterized by a permanent and 
increasing pressure of their dynamic environments to adapt to changing political and 
economic, professional and consumer expectations concerning the process and content of 
hospital services. Two general tendencies can be distinguished within the trend of hospital 
reforms: 
1. strategic re-positioning of the hospital with the need to redefine the range and mix of 
services (i.e. the distinction between core business and other services, balancing 
inpatient/outpatient services or acute/chronic/rehabilitative services, inclusion of 
educative elements, specialization of types of hospitals and departments, and 
integration with primary care and social services and intersectoral collaboration); 
2. assuring and improving quality of services (i.e. to improve the safety, 
appropriateness, effectiveness and efficiency of services and improve satisfaction of 
stakeholders, introducing different quality approaches, accreditation and put a 
stronger emphasis on evidence based medicine and patient’s rights) (7). 
 
To be able to identify the specific contributions of health promotion to such 
strategic re-positioning and quality improvement in hospitals, six general strategies for 
the three target groups (patients, staff and the community) were introduced (Table 1).  
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Table 1. Six general health promotion strategies for each group of stakeholders 
(patients, staff, and the community). 
Health promotion strategies 
1. Health promotion quality development of treatment and care, by empowerment of 
stakeholders for health promoting self-care/self-reproduction 
2. Health promotion quality development of treatment and care, by empowerment of 
stakeholders for health promoting co-production 
3. Health promotion quality development for health promoting and empowering hospital 
setting for stakeholders 
4. Provision of specific health promotion services – empowering illness management 
(patient education) for stakeholders 
5. Provision of specific health promotion services – empowering lifestyle development 
(health education) for stakeholders 
6. Provision of specific health promotion activities – participation in health promoting and 
empowering community development for stakeholders 
 
 
Service oriented strategies include quality improvement of already existing clinical 
and hotel services (strategies 1, 2) or strategies introducing new, primarily educative 
services with mid-term or long-term health effects (strategies 4, 5). Strategies can be 
distinguished according to their orientation of treating or managing specific diseases 
(strategies 2, 4) and strategies oriented at services for maintaining or improving positive 
health (strategies 1, 5). Concerning settings, strategies developing the hospital setting itself 
(strategy 3) can be distinguished from strategies of participation of the hospital in 
developing the community setting (strategy 6) or other settings within the community (e.g. 
workplaces or schools). By being oriented at improving health gain and not just clinical 
outcome, these six strategies do not only apply to patients (and their relatives), but in a 
somewhat modified way also to staff and members of the community the hospital serves 
and is situated in, resulting in eighteen core strategies for health promotion in hospitals (7, 
12). 
 
 
Dilemmas facing Health Promoting Hospitals  
The main perceived barriers faced in the development of HPH are shortages of funds, 
personnel, time management and professional skills. The WHO refers to the fact that most 
health professionals in the hospital setting do not readily associate health promotion as part 
of their role (25). In the past, the projects carried out within the HPH network were 
characterized by a more traditional focus on health education interventions for patients and 
to a lesser extent for staff (10). Similar problems to those stated above can be found 
throughout the HPH movement in the HPH Network Progress Reports (26). Nearly all of 
the European member states report commonly encountered problems. This is not 
surprising, however, and perhaps inevitable given that many European countries stress the 
lack of government-related policy support, lack of individual organizational management 
commitment and lack of resources set aside for health promotion in hospitals (27). Perhaps 
the main driver for HPH reform in Europe is the capacity for hospitals to affect and 
influence public health reform and therefore directly influence the health of their 
surrounding communities. Hospitals and their leaders are being held increasingly  
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accountable for the health status of local populations (28). This represents the greatest 
challenge for the HPH movement and perhaps its biggest failure to date. A broader vision 
would see the development of not just what could be termed as HPH, but institutions that 
could be classified as Public Health Hospitals. A Public Health Hospital is one that 
develops its staff to move away from increasing medicalized subspecialization to an 
increasing understanding of the wider health agenda (29). It does this as part of a health 
promoting capacity-building process that leads to an organization’s overall structural 
development, as well as offering a support structure for wider community health promotion 
initiatives through collaboration with public health agencies (30).  
Tountas and colleagues reported that effective planning of hospital health promotion 
activities is required so that the daily routine is not interrupted. Besides of personnel 
shortage and lack of funding, lack of health promotion background was found to be 
perceived as a significant problem (14). On the other hand, Polluste and colleagues 
compared the implementation of health promoting and quality-related activities in HPH 
and those hospitals which have not joined the HPH network (non-HPH) in Estonia. In the 
beginning of 2005, they conducted a postal survey among the top managers of fifty-four 
Estonian hospitals. The questionnaire was based on the WHO standards for HPH and on 
the set of the national quality assurance (QA) requirements for health services. The study 
demonstrated some significant differences in the uptake of health promotion and QA 
activities between HPH and non-HPH. For example, regular patient satisfaction studies 
were conducted in 83% of HPH and 46% of non-HPH (p<0.03) and 65% of HPH and 46% 
of non-HPH cooperated with various patient organizations (p<0.03). Systems for reporting 
and analysis of complications were implemented in 71% of HPH and 33% of non-HPH 
(p<0.03); also, the implementation of various guidelines was more developed in HPH. All 
HPH have carried out a risk analysis on the workplace and staff job satisfaction studies 
were conducted in 89% of HPH and 41% non-HPH (p<0.05). They concluded that the 
concepts of HPH and QA are closely related. Making progress in health promotion is 
accompanied with QA and vice versa. Implementation of health-promoting activities in 
hospitals promote the well-being and health of patients and hospital staff, and creates a 
supportive environment to provide safe and high-quality health services (31). To further 
develop HPH, effort needs to be made to ensure that hospital leaders and management are 
considered first. If managerial staff have an appropriate understanding of the concept and 
principles of HPH, then it is more likely that health promotion activities can be introduced 
into the daily workings of hospitals, and the necessary funds, personnel and training on 
health promotion skills be provided (32). 
It does appear, however, that the HPH movement is spreading rather than 
diminishing. The focus of the HPH projects is now enlarging, addressing also 
organizational and community issues such as a change of organizational culture and 
environmental issues. A future challenge of HPH is still to link organizational health 
promoting activities with continuous quality improvement programmes, making use of the 
apparent similarities such as the focus on continuous process and development, 
involvement and ownership, monitoring and measurement, and to incorporate the principle 
of health promotion into the organizational structure and culture (12). 
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CASE STUDY: MEETING THE COMPREHENSIVE HEALTH 
GOALS: THE CASE OF GOLNIK HOSPITAL, SLOVENIA 
New health promotion and disease prevention services  
The initial idea of HPH was focused on placing greater emphasis on health promotion and 
disease prevention, rather than on diagnostic and curative services alone. In public health, 
disease prevention is usually defined as primary disease prevention which prevents 
diseases from occurring, secondary prevention which detects disease at an early stage and 
prevents disease from developing, and tertiary prevention which prevents aggravation or 
recurrence of disease and secures maintenance of functional level (7). Traditionally, 
hospitals primarily take care of tasks that relate to secondary or tertiary prevention whereas 
the primary sector and other social institutions take care of primary prevention. It is, 
however, increasingly recognized that hospitals can play a significant role in linking all 
three levels of prevention in order to gain patients’ satisfactory outcome (33). The focus 
stays on effective treatment, but in order to optimize health gain, the outcome concept of 
hospitals has widened to include, in addition to clinical outcomes, also patient satisfaction, 
health-related quality of life, and health literacy. All of these aspects have to get the 
attention within the treatment process.  
There is international consensus that patients should be given recommendations, 
guidance, and support with regard to health promotion in hospitals (23). Health promotion 
secures that risk conditions are identified and that the patient has knowledge of the 
significance of these conditions, recommendations for changes, and active support for 
carrying out these changes. From this perspective follows that it makes sense to invest not 
only in clinical interventions, but also in other interventions to improve health, like 
educating patients for self-management and developing situations to make the »healthy 
choice the easy choice«. An important element is the activation of the patient’s individual 
resources and competences in coping with disease (28). A practical example for 
empowering patients for co-production would be diagnosis and treatment related patient 
information, training and counselling (e.g. by informing patients about how they can 
contribute to the recuperation process, by describing alternatives and side effects), in order 
to enable patients to participate in the diagnostic process (e.g. by providing all information 
needed); participate in treatment-related decision-making; actively participate in treatment 
and care processes (e.g. by complying with the prescriptions). Thus, health promotion and 
specific disease prevention form a continuum. 
 
 
Empowerment of patients for health promoting management of 
chronic disease 
Expert interventions in hospitals provide in general only a turning point in disease process, 
and a basis for recuperation or the successful management of chronic disease. Every 
contact with hospital based physicians either during hospitalization or ambulatory visit 
represents an ample opportunity to involve patients in diagnostic and therapeutic 
management of their medical condition. Personal experience of disease deterioration, even 
to a slight degree, generally makes patients susceptible to non-pharmacological and 
pharmacological interventions in which their active role is indispensable. The main part of 
recuperation or of the day-to-day disease management has to be performed primarily by 
the patients themselves, with specific professional support by the hospital, specialized 
services, or other health care services. This phase of the disease career lasts much longer  
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and is out of direct control of the hospital, but is crucial for the outcome of regaining health 
and quality of life.  
Hospitals have to take this perspective on the disease career into account by either 
providing necessary disease specific support by themselves or by referring patients to 
other, specialized providers in the health care system. The more complex and the more rare 
the disease and its treatment gets, the more likely it remains a task of the hospital itself, but 
this of course requires adequate legal and financial regulation which allows to provide 
these services systematically. One example of effective intervention of this type of services 
is the case of Golnik hospital, where introducing specific type of treatment for specific 
group of patients has developed from hospital vision to national clinical pathway 
implementation. 
 
 
Specific immunotherapy: concepts and principles 
Introduction 
Specific immunotherapy is a well established form of treatment of patients with some 
allergic diseases. Among main indications is allergic rhinitis. The goal of specific 
immunotherapy is to diminish the allergic response to allergens. The outcome of 
immunotherapy is a decrease in symptoms during allergen exposure, better response to 
medical therapy and decreased risk of new allergen sensitizations. In very few patients 
complete disappearance of the disease may be achieved as well.  
 
Selection of patients 
Immunotherapy is only effective in carefully selected patients. IgE mediated allergy has to 
be proven. Appropriate patients are those in whom: 
1. allergic symptoms are due to only one allergen or a group of cross reactive allergens; 
2. for symptomatic relief high and regular doses of systemic and local drugs are 
necessary; 
3. duration of the allergen exposure season is long. 
 
Clinical studies have shown that patients with multiple allergies do not benefit from 
immunotherapy. Other diseases which might be the predominant cause of patients’ 
symptoms should be excluded, like structural diseases of the nose and nonallergic rhinitis. 
Immunotherapy is effective only in patients, where allergy is the only/predominant 
mechanism of symptoms. 
 
Burden of immunotherapy for the health care system 
As immunotherapy is time consuming and requires excellent compliance by the patients in 
order to get an effect, immunotherapy is not suitable for patients with mild and short 
lasting allergic diseases, which are easily controlled with medications. It is important also 
to consider the costs of allergen extracts for immunotherapy which are substantial and the 
same for patient with severe as for the patient with mild disease.  
Immunotherapy has also unpleasant and even dangerous side effects. Local reactions 
at the site of allergen application (swelling, itching) are quite common; fortunately 
systemic allergic reactions are extremely rare in pollen and dust mite immunotherapy. Life 
threatening reactions are particularly common in patients with unstable asthma and patients 
with anaphylaxis.  
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Medical and pharmaceutical approach to organization of 
immunotherapy 
Immunotherapy should be offered only to those patients in whom high efficacy and low 
risk of side effects of the treatment is expected. However, the main interest of the 
producers and traders of allergen extracts is a widespread use of immunotherapy 
concerning safety more than efficacy of the treatment. In order to reach their goal, they run 
a promotion which is not always based on evidence derived from clinical studies. Sadly 
enough, many practicing medical doctors are not updated with the results of evidence 
based medicine, but get most medical information from pharmaceutical representatives and 
promotion leaflets (34).  
 
 
Introduction of sublingual immunotherapy in Slovenia 
In Slovenia subcutaneous immunotherapy (SCIT) has been used for decades. SCIT 
applications were mostly limited to the hospital based allergologists. Beside safety aspects 
the main reason for the limited use of immunotherapy was the way of reimbursement. 
Allergen extracts were not registered in Slovenia and were only purchased by the health 
institution on their own expense. Doctors were not able to make a prescription for the 
allergen extract for the pharmacy. For that reason private and community based 
allergologists were discouraged to prescribe immunotherapy and consequently didn’t get 
experience in selection and follow up of the patients on immunotherapy. 
In 2007 sublingual immunotherapy (SLIT) was registered in Slovenia and 
reimbursed by health insurance. That form of immunotherapy is suitable also for 
allergologists with only outpatient practice. As patients don’t need to visit doctor for 
monthly injections and the cost of allergen is reimbursed, we expected much higher 
interest in prescribing that form of immunotherapy. 
Clinical studies of SLIT showed comparable efficacy to SCIT when performed in 
carefully selected groups of mono/oligosensitized patients. In all clinical trials SLIT was 
performed with a single allergen or a combination of two allergens in full dose of each 
allergen. Moreover, studies showed marked dose response. Reducing the dose of allergen 
to one third, the effect of SLIT was undistinguishable from placebo. However, producers 
of allergen extracts offered and promoted using: 
1. many allergens, whose efficacy was not studied in clinical trials; 
2. non-standardized allergen extracts in low dose; 
3. mixtures of unrelated allergens.  
 
 
Expected negative effects of introduction of sublingual 
immunotherapy on health 
Allergologists in Golnik hospital, who are very experienced in immunotherapy, using it for 
years not only in respiratory allergy, but also in venom allergy, recognized the threat for 
health care system due to inefficient use of health care resources. Namely we expected: 
1. prescriptions of SLIT to patients, in whom there is only a weak indication; 
 
2. insufficient performance of SLIT, namely only prescribing of allergen and not 
guiding the patient through the process of SLIT; 
3. predominant prescribing of mixtures of allergens and even allergens with no clinical 
relevance. 
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For that reason we prepared a program for education of allergologists willing to 
prescribe SLIT and set up a national clinical pathway for SLIT. 
 
 
Activities for setting up a national clinical pathway for 
sublingual immunotherapy 
Activity 1 
First step was to negotiate the conditions for reimbursement of allergen extract with health 
care insurance company. It was decided, that a patient gets a fully reimbursed SLIT extract 
after agreement of allergy counsel that predefined criteria for SLIT are fulfilled. 
 
Activity 2 
Next step was the selection of the criteria for immunotherapy. We followed European 
guidelines for immunotherapy (35). We prepared a check-list where the allergologist 
marked the indication and the selection of the allergen for SLIT. Only allergens which 
were shown in randomized clinical trials to be effective were put on the list. Only one 
allergen could be selected for SLIT or in the case of two important non-cross reactive 
allergens, two separate SLIT were performed. The check list in fact offered the 
allergologist to become familiar with the standard for appropriate selection of patient and 
allergen for immunotherapy (Appendix). 
 
Activity 3 
Next step was a development of a document, which would guide the allergologist and the 
patient through the process of SLIT. Prescription of allergen extract must be made on time 
as the treatment has to begin 2 months before the pollen season. Patient should be 
instructed how to take the drug, familiar with the local side effect of the therapy, and 
adherent to therapy. For that reason a check list for the patient was prepared, where all 
important dates are put (date for the beginning of the therapy, dates of follow up visits, and 
a table where the patient confirms the use of allergen drops and reports possible side 
effects). In the beginning of the SLIT patients are offered a phone contact with the allergy 
nurse to clarify possible misunderstandings. Follow up visits are planned before the pollen 
season to provide the patient with the medications and at the top of the season to evaluate 
the efficacy of the SLIT. 
All the documents were put in a form of a booklet, which is owned by a patient but 
the copies of each filled page are put into the patient’s medical documentation file in the 
allergologist’s office. The cover of the booklet was used for the detailed explanation of 
SLIT to the patient, including the instruction for treatment of side effects. 
 
Activity 4 
Activities were undertaken to obtain a consensus of the members of the Slovenian 
Association of Allergy and Clinical Immunology on the content and the aim of the clinical 
pathway. The same approach was used for adult and paediatric patients. 
To facilitate the adherence of doctors with the clinical pathway, it was decided that 
the data on the first year of the immunotherapy would be analyzed and presented as a 
Slovenian study of introduction of the SLIT. We obtained some sponsorship for the 
analysis form the producer of the allergen extracts.  
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In the first year 90 adult patients were recruited by 12 allergologists. Forty-three 
patients were treated at Golnik hospital and 47 by other allergologists. Indications for SLIT 
were allergic rhinitis (seasonal 70, perennial 21) and asthma (31). In 2 patients SLIT was 
started after SCIT discontinuation because of side effects. Majority of patients (73) were 
treated with a singled allergen, 16 with a full dose of two allergens and only 1 with a 
mixture of allergens (Table 2).  
 
Table 2. Slovenian study of sublingual immunotherapy. 
ALLERGEN house dust mite grasses birch hazel ambrosia SUM 
MONOTHERAPY 16 31 17 1 8 73 
       
COMBINATION 
WITH: 
      
house dust mite - - - - -  
Grasses 3 - - - - 3 
Birch 1 4 - - - 5 
Hazel 0 1 7 - - 8 
ambrosia 0 0 0 0 - 0 
       
SUM 20 36 24 1 8 89 
* 1 patient was treated with a combination of grass, birch and hazel pollen. 
 
 
Conclusion 
SLIT was effectively introduced in accordance with evidence based medicine and 
European guidelines for immunotherapy (35). We believe that our approach reached the 
following goals: 
1. optimal clinical outcome of the treatment, namely the minimal possible symptoms of 
the allergic rhinitis during the period of allergen exposure;  
2. optimal patient-related outcome. With the empowerment of the patients we probably 
achieved a positive perception of the treatment by the patients and improved their 
satisfaction in spite of long lasting therapy. Finally, by well selected patients, well 
performed SLIT and appropriate follow up during the pollen season patients had 
better quality of life in spite of the long lasting difficult therapy and bothersome 
chronic disease; 
3. optimal health care system-related outcome, namely the best ratio between the cost 
and the outcome of the treatment. The health care resources were directed toward the 
patients, who were optimally selected and care was taken, that resources were used 
optimally.  
 
Proposal for introduction of sublingual immunotherapy is presented in Appendix. 
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EXERCISE 
Task 1 
From the selection of European HPH member states’ website addresses choose one and 
look at HPH activities. Try to find out if activities are carried out on all four areas of HPH 
strategy and discuss findings with your colleagues. 
European HPH member states’ website addresses: 
http://www.helse-stavanger.no (Norway) 
http://www.mfn.sk (Slovakia) 
http://www.elisabeth-essen.de (Germany)  
http://itk.ee (Estonia) 
http://www.vsshp.fi (Finland) 
 
Task 2 
After carefully reading the case study, try to develop your own programme for 
empowerment of patients for health promoting management of specific chronic disease. 
Compare your programme with ideas of your colleagues. 
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APPENDIX 
Proposal for introduction of sublingual immunotherapy (SLIT)∗  
Patient's name and surname: 
 
Date of birth: 
Allergologist's name and surname:  
 
Registry number: 
General practitioner's name and surname: 
 
Registry number: 
 
 
 
Clinical indications for SLIT 
 (one or more): 
 perennial allergic rhinitis 
 seasonal allergic rhinitis 
 moderate asthma 
Reason for SLIT introduction: 
 insufficient response on 
pharmacotherapy prescribed 
according to guidelines 
 complications with SCIT 
 patient doesn't want SCIT 
 
 
 
Intensity of rhinoconjunctivitis in last season/last year (fill in together with patient): 
  
no problem 
0 
some 
problem 
1 
moderate 
problem 
2 
a lot of 
problem 
3 
extreme 
problem 
4 
Sneezing           
Nasal congestion           
Runny nose           
Itching of the eyes           
Lachrymation           
Itching in oral cavity           
Itching in ear tubes           
Cough           
Dispnea           
Urticaria           
Fatigue           
 
                                                 
∗
 Send to: Allergy Council 
ADULTS: Bolnišnica Golnik KOPA, 4204 Golnik 
CHILDREN: UKC Pediatrična klinika, Vrazov trg 1, 1000 Ljubljana or UKC Maribor, Klinika za pediatrijo, Ljubljanska ul. 5, 2000 
Maribor 
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Medications used in the last year due to allergy: 
 as needed during season regularly 
systemic antihistaminic                   
  
nasal antihistaminic                               
  
antihistaminic eye drops                 
   
nasal glucocorticoid                            
  
inhalational glucocorticoid                     
   
antileucotriene                                         
  
bronchodilator                                        
  
systemic glucocorticoid                         
   
other: 
   
 
 
 
Allergic senzibilization: 
Senzibilization with allergens: Clinically the most important 
allergen (one or more): 
 house dust mite  house dust mite 
 grass pollen  grass pollen 
 hazel pollen  hazel pollen 
 birch pollen  birch pollen 
 weed pollen  weed pollen 
 other:  other: 
 
Senzibilization confirmed date__________ 
 
 
When are the problems with allergy most intensive: 
 throughout the year, without seasonal worsening 
 throughout the year, with relevant seasonal worsening, the worst in 
(months)____________ 
 predominantly seasonal, the worst in (months)__________ 
 
Pulmonary function testing Metacholin test 
 not performed 
 performed, last test date: 
________ 
VC % :______________ 
FEV1% :_____________ 
 not performed 
 performed, last test date: 
________ 
 positive 
 negative 
 
 
How many years does the patient have symptoms of allergic rhinitis or asthma? 
 up to 2 years        5 to 10 years 
 2 to 5 years            more than 10 years 
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Selection of allergen for SLIT: 
 house dust mite 
 grass pollen 
 hazel pollen 
 birch pollen 
 other (argumentation)________________________________________________ 
 
Allergologist who proposed introduction of SLIT  DATE 
__________________________________   __________ 
 
 
 
Patient case presented at the Allergy Council, date _____________________________ 
Allergy counsel agrees with proposal: YES NO 
      COMMENTARY______________________ 
 
Proposed initiation of SLIT: allergen 1 date _____________,  
allergen 2 date ________________ 
 
Head of the allergy counsel      DATE 
 
 
